Culture medium for inducing tolerant DC cells, culture method and application of culture medium
By adding granulocyte-macrophage colony stimulating factor, interleukin 4, transforming growth factor-β and glycyrrhizic acid to cell culture medium, the induction efficiency and activity of tolerant DC cells was significantly improved, and the existing technology was solved The problems of low efficiency and insufficient stability have achieved efficient and safe large-scale production.
Patent Information
- Application Number
- CN202411243633.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-05
- Publication Date
- 2024-11-19
AI Technical Summary
In the prior art, the induction of tolerant DC cells is inefficient and the stability is insufficient. The traditional methods have problems with safety and controllability, which are difficult to achieve in large-scale production.
提供一种包含粒细胞-巨噬细胞集落刺激因子、白细胞介素4、转化生长因子-β、甘草酸和血浆的培养基,通过这些成分的协同作用显著促进耐受性DC细胞的形成和分化,提高了诱导效率和细胞活性。
It significantly improves the induction efficiency of tolerant DC cells, obtains higher quantity and activity, and has high safety and controllability, which is suitable for large-scale production.
Smart Images

Figure CN118979013A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of cell culture, and in particular to a culture medium for inducing tolerance DC cells, a culture method and application thereof. Background Art
[0002] Tolerogenic dendritic cells (tDCs) are a type of antigen-presenting cells with immunosuppressive properties. They induce tolerance of effector cells by presenting antigens, thereby inhibiting the body's excessive immune rejection response. Tolerogenic DCs are usually regarded as semi-mature cells, with low expression levels of surface markers such as CD80, CD86, and CD40.
[0003] Although existing technical means, such as the use of cytokines such as IL-10, can induce the generation of tolerant DCs, the efficiency of this process is still low and it is difficult to achieve stability in large-scale production. Although the adenovirus induction method is effective, it has deficiencies in safety and controllability due to the immune response and potential side effects it may induce. It involves strict biosafety standards and technical requirements, which limits its scope of application and prospects.
[0004] Therefore, although the existing methods for inducing tolerant DCs provide a certain basis for research, they still face problems such as low efficiency and insufficient stability in practical applications. Summary of the invention
[0005] The present invention provides a culture medium, a culture method and an application for inducing tolerant DC cells, so as to solve the defects of the induced culture of tolerant DC cells in the prior art and realize the induced culture of a large number of tolerant DC cells.
[0006] The invention provides a culture medium for inducing tolerant DC cells, comprising a first basic culture medium, granulocyte-macrophage colony stimulating factor, interleukin 4, transforming growth factor-β, glycyrrhizic acid and plasma; wherein the concentration of the granulocyte-macrophage colony stimulating factor is 100-1000 U / mL, the concentration of the interleukin 4 is 10-50 ng / mL, the concentration of the transforming growth factor-β is 100-1000 U / mL, the concentration of the glycyrrhizic acid is 1-10 μM, and the concentration of the plasma is 5-10%.
[0007] According to a culture medium for inducing tolerance DC cells provided by the present invention, the first basic culture medium includes one of AIM-V culture medium, KBM-581 culture medium and RPMI-1640 culture medium.
[0008] According to the culture medium for inducing tolerant DC cells provided by the present invention, the concentration of the granulocyte-macrophage colony stimulating factor is 500 U / mL.
[0009] According to the culture medium for inducing tolerance DC cells provided by the present invention, the concentration of interleukin 4 is 50 ng / mL.
[0010] According to the culture medium for inducing tolerant DC cells provided by the present invention, the concentration of transforming growth factor-β is 700 U / mL.
[0011] The present invention provides a method for culturing tolerant DC cells, the method comprising:
[0012] Obtaining cells to be processed;
[0013] Purifying the cells to be treated to obtain purified cells;
[0014] Based on the culture medium described in any one of the first aspects of the present invention and the preset first culture time, the purified cells are cultured to obtain target cells.
[0015] According to a method for culturing tolerant DC cells provided by the present invention, the seeding density of the cells to be treated is 3 to 8×10 6 Pieces / mL;
[0016] The cells to be treated are PBMCs.
[0017] According to a method for culturing tolerant DC cells provided by the present invention, purifying the cells to be treated to obtain purified cells comprises:
[0018] The cells to be processed are sorted to obtain purified cells.
[0019] According to a method for culturing tolerant DC cells provided by the present invention, purifying the cells to be treated to obtain purified cells comprises:
[0020] The cells to be treated are cultured based on the second basal culture medium, and the suspended cells in the cells to be treated are discarded according to the preset first culture time to obtain purified cells.
[0021] A kit, characterized in that the kit comprises any one of the culture media described above, and the kit is used for culturing, inducing and / or preparing supernatant exosomes of tolerogenic DC cells.
[0022] The present invention proposes a culture medium, a culture method and an application thereof for inducing tolerant DC cells. The culture medium of the present invention comprises a first basal culture medium, granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin 4 (IL-4), transforming growth factor-β (TGF-β), glycyrrhizic acid and plasma, and its content is precisely determined. Through the synergistic effect of these components, the formation of tolerant DC cells is significantly promoted. Glycyrrhizic acid can significantly induce the differentiation of DC cells into tolerant DC cells and enhance their immunosuppressive ability. At the same time, GM-CSF and IL-4 act together on the differentiation of DC cells, and TGF-β and glycyrrhizic acid jointly promote the formation of an immunosuppressive environment, which is conducive to the generation of tolerant DC. The present invention greatly improves the induction efficiency of tolerant DC cells. Compared with traditional methods, the present invention is simple and easy to implement, can obtain tolerant DC cells with higher quantity and activity in a shorter time, and has higher safety and controllability, and is suitable for promotion and use in large-scale tolerant DC cell induction culture. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the following briefly introduces the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0024] Figure 1 It is a schematic diagram of the expression level of DC cell co-stimulatory molecule HLA-DR in different experimental examples and comparative examples provided by the present invention;
[0025] Figure 2 It is a schematic diagram of the expression level of DC cell co-stimulatory molecule CD80 in different experimental examples and comparative examples provided by the present invention;
[0026] Figure 3 It is a schematic diagram of the expression level of DC cell co-stimulatory molecule CD83 in different experimental examples and comparative examples provided by the present invention;
[0027] Figure 4 It is a schematic diagram of the expression level of DC cell co-stimulatory molecule CD86 in different experimental examples and comparative examples provided by the present invention. DETAILED DESCRIPTION
[0028] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be clearly and completely described below in conjunction with the drawings of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0029] The invention provides a culture medium for inducing tolerant DC cells. The culture medium comprises a first basic culture medium, granulocyte-macrophage colony stimulating factor, interleukin 4, transforming growth factor-β, glycyrrhizic acid and plasma; wherein the concentration of the granulocyte-macrophage colony stimulating factor is 100-1000 U / mL, the concentration of the interleukin 4 is 10-50 ng / mL, the concentration of the transforming growth factor-β is 100-1000 U / mL, the concentration of the glycyrrhizic acid is 1-10 μM, and the concentration of the plasma is 5-10%.
[0030] The first basal medium is the basis of cell culture, providing the cells with the basic nutrients, suitable pH and osmotic pressure required for growth. In the present embodiment, one of AIM-V medium, KBM-581 medium or RPMI-1640 medium can be selected as the first basal medium. AIM-V medium is a serum-free medium that can be used for the proliferation of DC cells. KBM-581 and RPMI-1640 are widely used in immune cell culture. In addition, other basal mediums suitable for immune cell culture can be used as the first basal medium of the present embodiment, such as AIM-V medium with 10% FBS (Fetal Bovine Serum). The first basal medium provides the necessary support for the cells.
[0031] GM-CSF can significantly increase the proliferation and maturation of dendritic cells and enhance their antigen presentation ability. In the concentration range of 100-1000U / mL, GM-CSF can increase the number and activity of DC cells and enhance their antigen presentation ability. IL-4 can enhance the maturation and function of dendritic cells. In the concentration range of 10-50ng / mL, IL-4 can effectively promote the generation and maturation of DC and maintain its immunoregulatory properties. As a potent immunosuppressive factor, TGF-β can induce DC cells to transition to a tolerant state by inhibiting the production of cytokines and reducing the expression of co-stimulatory molecules. At the same time, in the concentration range of 100-1000U / mL, TGF-β effectively promotes the transformation of immature DC cells to tolerant DC rather than mature DC cells by enhancing the immunosuppressive properties of its DC cells. The addition of plasma provides additional support for the culture of tolerant DC cells. Plasma contains a variety of bioactive components, such as growth factors, cytokines and nutrients, which can provide additional support for cells, improve cell survival rate and enhance their activity, and may promote the tolerance characteristics of DC cells. In the concentration range of 5-10%, plasma can effectively supplement the nutritional needs of cells and provide a culture environment closer to the physiological state for cells. The use of autologous plasma can further enhance this effect and make the culture environment closer to the in vivo environment.
[0032] Glycyrrhizic acid can affect the expression of DC cell surface markers, thereby making DC cells mature and differentiate more towards tolerant DC cells. At the same time, it can also promote the expression of tolerance-related cytokines, thereby maintaining the tolerance characteristics of tolerant DC cells.
[0033] Based on the above-mentioned culture medium for inducing tolerant DC cells, immature DC cells can be induced and cultured to obtain tolerant DC cells. In one embodiment, the above-mentioned culture medium is directly used to culture and induce cells to be treated, such as PBMC, containing immature DC cells to obtain tolerant DC cells. In order to improve the induction efficiency of the above-mentioned culture medium and maximize the induction and proliferation effect on tolerant DC cells, the present invention also provides a culture method for inducing tolerant DC cells. The method comprises:
[0034] S10, obtaining cells to be processed.
[0035] First, cells to be treated are obtained, which are cells, tissues, etc. that have the ability to differentiate into tolerant DC cells, such as PBMC. Taking PBMC as an example, Ficoll method (density gradient centrifugation method) can be used to extract from peripheral blood.
[0036] S20, purifying the cells to be processed to obtain purified cells.
[0037] Specifically, the cells to be treated may contain a variety of different types of cells, and some cells, such as lymphocytes, can be purified in advance to exclude them to improve the differentiation and proliferation efficiency. The cell density selected in this embodiment is 3 to 8×10 6 Pieces / mL.
[0038] The first purification method provided in this embodiment is to culture the cells to be treated based on the second basal culture medium, and discard the suspended cells in the cells to be treated according to the preset second culture time to obtain purified cells. Specifically, the second culture time refers to the time for culturing the cells to be treated, which is 1 to 4 hours, preferably 2 hours. The second basal culture medium is independently selected relative to the first basal culture medium, such as the above-mentioned AIM-V culture medium, KBM-581 culture medium, etc. Since early DC cells are in an easy-to-adhere state and lymphocytes are suspended culture cells, purified cells including early DC cells are obtained by short-term adhesion screening, thereby increasing the content and induction efficiency of tolerant DC cells after induced culture.
[0039] Taking PBMC as the cells to be treated as an example, the PBMC cells are resuspended in the above-mentioned second culture medium preheated at 37°C and inoculated in a culture vessel, such as a 6-well plate, a T25 culture flask, or a T75 culture flask. Then, the cells are cultured in a carbon dioxide incubator for 2 hours. After 2 hours, the suspended cells are discarded, and the retained adherent cells are purified cells. To facilitate subsequent experiments, the first purification method is used in the subsequent experimental group in this embodiment.
[0040] The second purification method provided in this embodiment is to sort the cells to be treated by sorting the surface markers, such as Ly6C on the surface of mouse monocytes and CD14 (Cluster of Differentiation 14) on the surface of human monocytes. The cells to be treated can be sorted by using the antigen-antibody binding, magnetic beads, flow cytometry, etc., and the sorted cells can be used as purified cells for subsequent induction culture.
[0041] S30, culturing the purified cells based on the tolerance-inducing DC cell culture medium and a preset first culture time to obtain target cells.
[0042] Specifically, the first culture time is the culture time of the purified cells using the culture medium for inducing tolerance DC cells, preferably 5 to 10 days, and this embodiment uniformly adopts 7 days as the first culture time. After 7 days of culture, the purified cells in the culture vessel are collected to obtain target cells containing tolerance DC cells. In order to reduce the damage of the surface proteins of the tolerance DC cells, the cells are scraped by a cell scraper.
[0043] In order to verify the culture medium and culture method of the tolerance-inducing DC cells, the first basic culture medium adopts AIM-V culture medium, and the experimental examples and comparative examples are designed to have the following compositions:
[0044]
[0045]
[0046] The control examples and experimental examples were tested by multicolor flow cytometry to analyze the expression levels of costimulatory molecules on the surface of target cells, including HLA-DR (Human leukocyte antigen), CD80 (Cluster of Differentiation 80), CD83 (Cluster of Differentiation 83) and CD86 (Cluster of Differentiation 86). In tolerant DC cells, their expressions were maintained at medium to low levels. After analysis and identification, the results are shown in the following table.
[0047] Table 1. Proportion of target cell co-stimulatory molecules positive (%)
[0048] Group HLA-DR CD80 CD83 CD86 Comparative Example 1 96.47±0.15 98.33±0.32 91.37±0.21 71.93±0.55 Experimental Example 1 <![CDATA[57.23±2.34 a ]]> <![CDATA[67.70±1.61 a ]]> <![CDATA[90.20±0.10 a ]]> <![CDATA[39.33±0.32 a ]]> Experimental Example 2 <![CDATA[53.00±0.69 a ]]> <![CDATA[64.17±0.80 a,b ]]> <![CDATA[86.53±0.21 a,b ]]> <![CDATA[37.73±0.74 a,b ]]> Experimental Example 3 <![CDATA[52.00±2.01 a,b ]]> <![CDATA[58.90±1.61 a,b ]]> <![CDATA[85.53±0.25 a,b ]]> <![CDATA[30.93±0.57 a,b ]]>
[0049] The superscript a in the table indicates that there is a significant difference compared with Comparative Example 1, P < 0.05; the superscript b indicates that there is a significant difference compared with Experimental Example 1, P < 0.05.
[0050] like Figures 2 to 4 As shown, compared with the comparative example, the expression level of co-stimulatory molecules in the target cells of Experimental Examples 1 to 3 was significantly reduced, and the content of tolerant DC cells was significantly increased. In Experimental Examples 2 to 3 containing glycyrrhizic acid, the expression level of co-stimulatory molecules was significantly reduced. Therefore, the culture medium containing glycyrrhizic acid provided in this embodiment can greatly increase the content of induced tolerant DC cells. The culture medium is easy to obtain, and the culture induction method is simple, fast and stable, which can meet the needs of large-scale tolerant DC cells.
[0051] The present invention also provides a kit, which includes the culture medium as described above, and the kit can be used in inducing tolerant DC cells, preparing supernatant exosomes, etc. Through the culture medium, the content of tolerant DC cells can be efficiently increased, based on the fact that this exosome is rich in a variety of tolerant DC cell secretion factors.
[0052] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A culture medium for inducing tolerant DC cells, characterized in that: include: A first basal culture medium, granulocyte-macrophage colony stimulating factor, interleukin 4, transforming growth factor-β, glycyrrhizic acid and plasma; wherein the concentration of the granulocyte-macrophage colony stimulating factor is 100-1000 U / mL, the concentration of the interleukin 4 is 10-50 ng / mL, the concentration of the transforming growth factor-β is 100-1000 U / mL, the concentration of the glycyrrhizic acid is 1-10 μM, and the concentration of the plasma is 5-10%.
2. The culture medium for inducing tolerance DC cells according to claim 1, characterized in that The first basic culture medium includes one of AIM-V culture medium, KBM-581 culture medium and RPMI-1640 culture medium.
3. The culture medium for inducing tolerance DC cells according to claim 1, characterized in that The concentration of the granulocyte-macrophage colony stimulating factor is 500 U / mL.
4. The culture medium for inducing tolerance DC cells according to claim 1, characterized in that: The concentration of interleukin-4 is 50 ng / mL.
5. The culture medium for inducing tolerance DC cells according to claim 1, characterized in that: The concentration of transforming growth factor-β is 700 U / mL.
6. A method for culturing tolerant DC cells, characterized in that: The method comprises: Obtaining cells to be processed; purifying the mixed cells to obtain purified cells; Based on the culture medium described in any one of claims 1 to 5 and the preset first culture time, the purified cells are cultured to obtain target cells.
7. The culture method according to claim 6, characterized in that: The seeding density of the cells to be treated is 3 to 8×10 6 Pieces / mL; The cells to be treated are PBMCs.
8. The culture method according to claim 6, characterized in that: Purifying the cells to be treated to obtain purified cells comprises: The cells to be processed are sorted to obtain purified cells.
9. The culture method according to claim 6, characterized in that: Purifying the mixed cells to obtain purified cells comprises: The cells to be treated are cultured based on the second basal culture medium, and the suspended cells in the cells to be treated are discarded according to a preset second culture time to obtain purified cells.
10. A kit, characterized in that: The kit comprises the culture medium according to any one of claims 1 to 5, and is used for the culture, induction and / or supernatant exosome preparation of tolerogenic DC cells.
